Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review of the Most Updated Literature

Pulmonary endarterectomy (PEA) is the treatment of choice in case of chronic thromboembolic pulmonary hypertension (CTEPH). PEA is performed by an increasing number of surgeons; however, the reported outcomes are limited to a few registries or to individual centers’ experiences. This systematic review focuses on pre-operative evaluation, intra-operative procedure and post-operative results in patients submitted to PEA for CTEPH. The literature included was searched using a formal strategy, combining the terms “pulmonary endarterectomy” AND “chronic pulmonary hypertension” and focusing on studies published in the last 5 years (2017–2022) to give a comprehensive overview on the most updated literature. The selection of the adequate surgical candidate is a crucial point, and the decision should always be performed by expert multidisciplinary teams composed of surgeons, pulmonologists and radiologists. In all the included studies, the surgical procedure was performed through a median sternotomy with intermittent deep hypothermic circulatory arrest under cardiopulmonary bypass. In case of residual pulmonary hypertension, alternative combined treatments should be considered (balloon angioplasty and/or medical therapy until lung transplantation in highly selected cases). Short- and long-term outcomes, although not homogenous across the different studies, are acceptable in highly experienced CTEPH centers.

[1]  P. Liu,et al.  Duration of regional cerebral oxygen saturation under 40% is a risk factor for neurological injury following pulmonary thromboendarterectomy: A prospective observational study , 2022, Journal of cardiac surgery.

[2]  U. Sartipy,et al.  Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension , 2022, Pulmonary circulation.

[3]  S. Martin-Suarez,et al.  Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension: a systematic review. , 2022, Annals of cardiothoracic surgery.

[4]  Mrinal Mandal,et al.  Pulmonary Thromboendarterectomy Without Circulatory Arrest , 2022, Brazilian journal of cardiovascular surgery.

[5]  A. Dell’Amore,et al.  End-stage chronic thromboembolic pulmonary hypertension: is there still room for lung transplantation?-the past, the present and the future. , 2021, Annals of cardiothoracic surgery.

[6]  Jeffrey R. Terry,et al.  Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry , 2021, Chest.

[7]  H. Ogino,et al.  Efficacy and safety of balloon pulmonary angioplasty for residual pulmonary hypertension after pulmonary endarterectomy. , 2021, International journal of cardiology.

[8]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.

[9]  H. Ghofrani,et al.  Interventional and pharmacological management of chronic thromboembolic pulmonary hypertension. , 2021, Respiratory medicine.

[10]  M. Humbert,et al.  ERS statement on chronic thromboembolic pulmonary hypertension , 2020, European Respiratory Journal.

[11]  H. Schäfers,et al.  Long-term outcomes after pulmonary endarterectomy in 499 patients over a 20-year period. , 2020, The Annals of thoracic surgery.

[12]  E. Kretov,et al.  Pulmonary Artery Denervation for Patients With Residual Pulmonary Hypertension After Pulmonary Endarterectomy. , 2020, Journal of the American College of Cardiology.

[13]  E. Fadel,et al.  Limitations of right ventricular annular parameters in the early postoperative period following pulmonary endarterectomy: an observational study. , 2020, Interactive cardiovascular and thoracic surgery.

[14]  M. Newnham,et al.  CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension , 2020, European Respiratory Journal.

[15]  F. Jatene,et al.  Use of medical therapies before pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension patients with severe hemodynamic impairment , 2020, PloS one.

[16]  C. Eichstaedt,et al.  Supervised exercise training in patients with chronic thromboembolic pulmonary hypertension (CTEPH) as early follow-up treatment after pulmonary endarterectomy (PEA) – a prospective cohort study , 2020, Pneumologie.

[17]  Yun-hu Song,et al.  Preoperative platelet count, preoperative hemoglobin concentration and deep hypothermic circulatory arrest duration are risk factors for acute kidney injury after pulmonary endarterectomy: a retrospective cohort study , 2019, Journal of Cardiothoracic Surgery.

[18]  Y. Ozaki,et al.  Predictors of Outcomes after Surgery for Chronic Thromboembolic Pulmonary Hypertension. , 2019, The Annals of thoracic surgery.

[19]  B. Ji,et al.  Perfusion strategy and mid-term results of 58 consecutive pulmonary endarterectomy , 2019, Perfusion.

[20]  Wei Huang,et al.  Residual pulmonary hypertension after pulmonary endarterectomy: A meta‐analysis , 2018, The Journal of thoracic and cardiovascular surgery.

[21]  J. Wild,et al.  The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension , 2018, European Respiratory Journal.

[22]  Y. Okita,et al.  Sequential Hybrid Therapy With Pulmonary Endarterectomy and Additional Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension , 2018, Journal of the American Heart Association.

[23]  M. Humbert,et al.  IMPACT OF INITIATION OF BALLOON PULMONARY ANGIOPLASTY PROGRAM ON REFERRAL OF PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION TO SURGERY , 2018 .

[24]  S. Sihag,et al.  Quantifying the learning curve for pulmonary thromboendarterectomy , 2017, Journal of Cardiothoracic Surgery.

[25]  J. Nielsen-Kudsk,et al.  Results from more than 20 years of surgical pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension in Denmark , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[26]  M. Richter,et al.  An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan , 2017, European Respiratory Review.

[27]  E. Fadel,et al.  Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension , 2017, European Respiratory Review.

[28]  R. Ristl,et al.  Outcome after surgical treatment of chronic thromboembolic pulmonary hypertension: dealing with different patient subsets. A single-centre experience. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[29]  M. Madani Surgical Treatment of Chronic Thromboembolic Pulmonary Hypertension: Pulmonary Thromboendarterectomy. , 2016, Methodist DeBakey cardiovascular journal.

[30]  P. Dartevelle,et al.  Operability assessment in CTEPH: Lessons from the CHEST-1 study. , 2016, The Journal of thoracic and cardiovascular surgery.

[31]  H. Ghofrani,et al.  Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial. , 2016, The Lancet. Respiratory medicine.

[32]  J. Barberà,et al.  Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry , 2016, Circulation.

[33]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2015, European Respiratory Journal.

[34]  D. Jenkins Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension , 2015, European Respiratory Review.

[35]  H. Ghofrani,et al.  Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2) , 2014, European Respiratory Journal.

[36]  M. Madani,et al.  Chronic thromboembolic pulmonary hypertension. , 2014, The Lancet. Respiratory medicine.

[37]  G. Stone,et al.  Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension). , 2013, Journal of the American College of Cardiology.

[38]  Chen Wang,et al.  Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. , 2013, The New England journal of medicine.

[39]  M. Madani,et al.  Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. , 2012, The Annals of thoracic surgery.

[40]  J. Yuan,et al.  Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding , 2012, European Respiratory Journal.

[41]  W. Klepetko,et al.  Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. , 2011, The Journal of thoracic and cardiovascular surgery.

[42]  D. Freed,et al.  Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. , 2011, The Journal of thoracic and cardiovascular surgery.

[43]  Kurt W. Jensen,et al.  Pulmonary Hypertensive Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension Before Pulmonary Thromboendarterectomy , 2009, Circulation.

[44]  N. Westerhof,et al.  Predictors of mortality in inoperable chronic thromboembolic pulmonary hypertension. , 2009, Respiratory medicine.

[45]  W. Auger,et al.  Chronic thromboembolic pulmonary hypertension. , 2009, Seminars in respiratory and critical care medicine.

[46]  A. Vuylsteke,et al.  Pulmonary endarterectomy is possible and effective without the use of complete circulatory arrest--the UK experience in over 150 patients. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[47]  W. Klepetko,et al.  Predictors of Outcome in Chronic Thromboembolic Pulmonary Hypertension , 2007, Circulation.

[48]  P. Mikus,et al.  Pulmonary endarterectomy: is there an alternative to profound hypothermia with cardiocirculatory arrest? , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[49]  P. Thistlethwaite,et al.  Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. , 2002, The Journal of thoracic and cardiovascular surgery.

[50]  K. Wrabec,et al.  Prognostic factors in medically treated patients with chronic pulmonary embolism. , 2001, Chest.

[51]  K. Mogi,et al.  Surgical Treatment for Chronic Pulmonary Thromboembolism Under Cardiopulmonary Bypass with Selective Cerebral Perfusion , 2001, Surgery Today.